Race and response to neoadjuvant chemotherapy according to MammaPrint risk.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.578
Abstract: 578 Background: African-American (AA) women with breast cancer have a less favorable prognosis, likely due to differences in tumor biology. This is not only driven by the higher rate of triple negative/basal tumors in patients… read more here.
Keywords: chemotherapy; response; biology; mammaprint ... See more keywords